![]() |
|
|
| |
||
| |
||
|
![]() |
|
| |
||
Sansal I., Sellers W.R. The Biology and Clinical Relevance of
the PTEN Tumor Suppressor Pathway. Febbo P.G. and Sellers W. R. Use of expression analysis to predict outcome after radical prostatectomy. J Urol. 170 (Dec): S11-S20. download pdf Sellers W.R. and M. Loda. 2002. The EZH2 polycomb transcriptional repressor- a marker or mover of metastatic prostate cancer? Cancer Cell 2(5):349-350. download pdf Paez J.G. and W.R.Sellers. 2002. PI3/PTEN/ALT Pathway- A Critical Mediator of Ongoing Signaling. Ed. David Frank, 'Signal Transduction in Cancer' Kluwer Academic Publishers, Boston. pp 1-6. download pdf Sellers, W.R. 2001. PTEN Review for the Cancer Encyclopedia 'Encyclopedic Reference of Cancer' Manfred Schwab (Ed.) 734-738. download pdf Vazquez, F. and W. R. Sellers. 2000. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3- kinase signaling. Biochim Biophys Acta. 1470: M21-35. download pdf Ramaswamy, S. and W. R. Sellers. 2000. PTEN: A prostate cancer tumor suppressor gene. The Prostate Journal. 2: 52-61. Sellers, W. R. and D. E. Fisher. 1999. Apoptosis and cancer drug targeting. J Clin Invest. 104: 1655-61. download pdf Sellers, W. R. and W. G. Kaelin, Jr. 1997. Role of the retinoblastoma protein in the pathogenesis of human cancer. Journal of Clinical Oncology. 15: 3301-12. Sellers, W. R. and W. G. Kaelin. 1996. RB as a modulator of transcription. Biochimica et Biophysica Acta. 1288: M1-5. download pdf |
||
|
[
back to top ]
|